CATALOGO DEI PRODOTTI DELLA RICERCA

BRONTE, Vincenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.212
EU - Europa 10.462
AS - Asia 7.294
SA - Sud America 1.015
AF - Africa 251
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 6
Totale 30.272
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.048
RU - Federazione Russa 3.457
SG - Singapore 3.164
GB - Regno Unito 2.920
CN - Cina 1.920
IT - Italia 1.051
HK - Hong Kong 813
BR - Brasile 805
DE - Germania 635
FR - Francia 544
VN - Vietnam 543
FI - Finlandia 541
IE - Irlanda 449
SE - Svezia 354
KR - Corea 268
UA - Ucraina 152
IN - India 118
NG - Nigeria 105
NL - Olanda 97
CA - Canada 87
TR - Turchia 80
AR - Argentina 77
JP - Giappone 70
ID - Indonesia 64
ZA - Sudafrica 49
BD - Bangladesh 47
ES - Italia 47
MX - Messico 45
AT - Austria 41
PL - Polonia 33
EC - Ecuador 32
IQ - Iraq 32
BE - Belgio 30
CO - Colombia 27
AU - Australia 23
PK - Pakistan 21
MA - Marocco 19
PH - Filippine 18
VE - Venezuela 17
SA - Arabia Saudita 16
PY - Paraguay 15
CZ - Repubblica Ceca 14
TN - Tunisia 14
EG - Egitto 13
PE - Perù 13
KE - Kenya 12
UZ - Uzbekistan 12
MY - Malesia 11
CL - Cile 10
AZ - Azerbaigian 9
BO - Bolivia 9
TG - Togo 9
AE - Emirati Arabi Uniti 8
AL - Albania 8
BJ - Benin 8
IL - Israele 8
NZ - Nuova Zelanda 8
OM - Oman 8
UY - Uruguay 8
DZ - Algeria 7
LT - Lituania 7
TW - Taiwan 7
CH - Svizzera 6
CR - Costa Rica 6
DK - Danimarca 6
HU - Ungheria 6
JM - Giamaica 6
JO - Giordania 6
LB - Libano 6
RO - Romania 6
SI - Slovenia 6
BY - Bielorussia 5
IR - Iran 5
LV - Lettonia 5
NP - Nepal 5
AM - Armenia 4
AO - Angola 4
EE - Estonia 4
MK - Macedonia 4
NI - Nicaragua 4
NO - Norvegia 4
PT - Portogallo 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
ET - Etiopia 3
GR - Grecia 3
GT - Guatemala 3
HR - Croazia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
LU - Lussemburgo 3
PA - Panama 3
PS - Palestinian Territory 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
AD - Andorra 2
BH - Bahrain 2
CY - Cipro 2
DO - Repubblica Dominicana 2
Totale 30.229
Salva come PNG Salva come JPEG
Città #
Southend 2.673
Singapore 1.650
Ashburn 1.431
Jacksonville 1.243
Moscow 1.051
San Jose 1.018
Chandler 857
Woodbridge 851
Hong Kong 793
Dallas 724
Ann Arbor 635
Verona 614
Houston 443
Dublin 437
The Dalles 409
Beijing 300
Lawrence 220
Princeton 220
Wilmington 218
Los Angeles 206
New York 185
Munich 171
Ho Chi Minh City 167
Helsinki 143
Nanjing 132
Shenyang 119
Jinan 116
Buffalo 106
Hanoi 104
Abuja 102
Council Bluffs 89
Sindelfingen 84
Columbus 81
Tianjin 78
Milan 77
Redmond 75
São Paulo 72
Redondo Beach 67
Hebei 66
Tokyo 60
Santa Clara 57
Nanchang 55
Haikou 51
Orem 51
Hangzhou 49
Ningbo 49
San Francisco 49
Zhengzhou 48
Changsha 44
Jakarta 43
Guangzhou 42
London 41
Chicago 39
Seattle 39
Amsterdam 36
Jiaxing 35
Taizhou 34
Toronto 34
Frankfurt am Main 33
Turku 32
Brooklyn 31
Norwalk 31
Seoul 31
Brussels 29
Chennai 29
Johannesburg 28
Nuremberg 28
Stockholm 28
Dong Ket 27
Phoenix 27
Boardman 25
Haiphong 25
Taiyuan 25
Boston 24
Montreal 24
Warsaw 24
Atlanta 23
Redwood City 22
Rio de Janeiro 22
Da Nang 21
Vienna 21
Brasília 20
Dearborn 20
Denver 20
Dongguan 20
Fuzhou 20
Falls Church 19
Washington 19
Belo Horizonte 18
Madrid 17
Manchester 17
New Delhi 17
Lappeenranta 16
Grafing 15
Paris 15
Mexico City 14
Quito 14
Ankara 13
Fairfield 13
Fortaleza 13
Totale 19.813
Salva come PNG Salva come JPEG
Nome #
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 307
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer 294
MAP Kinase inhibition reshapes tumour microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages 291
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Associated to a B7-1-Expressing Tumor Cell Vaccine Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer. 282
Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma 258
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 251
CD66b-CD64dimCD115- cells in the human bone marrow represent neutrophil-committed progenitors 250
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 237
Deciphering the state of immune silence in fatal COVID-19 patients 228
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer 223
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 219
Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells. 216
Feasibility of telomerase-specific adoptive T-cell therapy for B-cell chronic lymphocytic leukemia and solid malignancies 215
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 214
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 214
Autoimmune B-cell lymphopenia after successful adoptive therapy with telomerase-specific T lymphocytes. 213
Baricitinib restrains the immune dysregulation in patients with severe COVID-19 213
Antigen specificity of immune suppression by myeloid-derived suppressor cells. 208
Altered macrophage differentiation and immune dysfunction in tumor development. 205
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease 204
Disabled homolog 2 controls pro-metastatic activity of tumor-associated macrophages 203
Antitumor vaccination: where we stand. 201
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers 200
Adoptive immunotherapy of experimental tumors using cytotoxic lymphocytes to carry and deliver toxins 198
Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis 195
A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). 192
Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen. 191
Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression 191
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 190
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC 188
Adoptive transfer of lymphokine-activated killer cells loaded with 4'-deoxy-4'-iododoxorubicin: therapeutic effect in mice bearing lung metastases. 187
Antitumour efficacy of lymphokine-activated killer cells loaded with ricin against experimentally induced lung metastases. 187
Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine. 186
Human Anti Cancer Cytokine Induced Killer Cells and TheirInteraction With the Host Immune System 184
Anti-tumor activity of cytotoxic T lymphocytes elicited with recombinant and synthetic forms of a model tumor-associated antigen. 183
Role of P2z purinergic receptors in ATP-mediated killing of tumor necrosis factor (TNF)-sensitive and TNF-resistant L929 fibroblasts. 181
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 179
A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells. 178
4PD Functionalized Dendrimers: A Flexible Tool for In Vivo Gene Silencing of Tumor-Educated Myeloid Cells 175
The Emerging Immunological Role of Post-Translational Modifications by Reactive Nitrogen Species in Cancer Microenvironment 174
Platelets promote thromboinflammation in SARS-CoV-2 pneumonia 172
Anatomically restricted synergistic antiviral activities of innate and adaptive immune cells in the skin. 171
The immune modulatory effects of umbilical cord-derived mesenchymal stromal cells in severe COVID-19 pneumonia 171
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 171
mTOR and STAT3 Pathway Hyper-Activation is Associated with evated Interleukin-6 Levels in Patients with Shwachman-Diamond Syndrome: Further Evidence of Lymphoid Lineage Impairment 168
Activation of p53 in Immature Myeloid Precursor Cells Controls Differentiation into Ly6c+CD103+Monocytic Antigen-Presenting Cells in Tumors 167
MDSCs in cancer: Conceiving new prognostic and therapeutic targets 167
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy 161
The Endless Saga of Monocyte Diversity 160
Adipocytes and Neutrophils Give a Helping Hand to Pancreatic Cancers 159
Characterization of Myeloid-derived Suppressor Cells in a Patient With Lung Adenocarcinoma Undergoing Durvalumab Treatment: A Case Report 159
Detection and functional evaluation of arginase-1 isolated from human PMNs and murine MDSC 158
The cross-talk between myeloid and mesenchymal stem cells of human bone marrow represents a biomarker of aging that regulates immune response and bone reabsorption 158
Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. 157
Anti-L-selectin monoclonal antibody treatment in mice enhances tumor growth by preventing CTL sensitization in peripheral lymph nodes draining the tumor area. 156
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells. 156
Myeloid-derived suppressor cell heterogeneity in human cancers 155
Local ablation disrupts immune evasion in pancreatic cancer 154
Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer 148
Transcription factors in myeloid-derived suppressor cell recruitment and function. 148
Interleukin-10 enhances the therapeutic effectiveness of a recombinant poxvirus-based vaccine in an experimental murine tumor model. 145
New idrosoluble furoxan derivatives having antitumoral activity 145
Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. 144
Nitric oxide furoxan derivative compounds endowed with antitumoral activity 143
GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironment 142
Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen. 141
PDE5 INHIBITOR COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY 141
IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients. 140
Costimulation enhances the active immunotherapy effect of recombinant anticancer vaccines. 139
Interfacing polymeric scaffolds with primary pancreatic ductal adenocarcinoma cells to develop 3D cancer models. 139
Use of myeloid cell biomarkers for the diagnosis of cancer. 138
Nitric oxide affects immune cells bioenergetics: long-term effects of nitric-oxide derivatives on leukaemic Jurkat cell metabolism 138
Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages 136
IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice. 134
Role of arginine metabolism in immunity and immunopathology. 134
Peripheral blood immunophenotyping in a large cohort of patients with Shwachman-Diamond syndrome 133
Therapeutic targeting of myeloid-derived suppressor cells. 132
Immune tolerance to tumor antigens occurs in a specialized environment of the spleen. 132
Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapy 132
Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. 132
Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation. 131
Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells 131
Preventive vaccination with telomerase controls tumor growth in genetically engineered and carcinogen-induced mouse models of cancer. 130
Derangement of immune responses by myeloid suppressor cells. 130
Resistance of lymphokine-activated T lymphocytes to cell-mediated cytotoxicity. 130
Arginase 1-Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti-PD-1 Checkpoint Blockade. 129
Leukocyte infiltration in cancer creates an unfavorable environment for antitumor immune responses: a novel target for therapeutic intervention. 129
Responses of mouse lymphocytes to extracellular ATP. II. Extracellular ATP causes cell type-dependent lysis and DNA fragmentation. 129
Plasmacytoid Dendritic Cell, Slan+-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients 128
IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression. 128
Meccanismi molecolari della lisi mediata dai linfociti citotossici 128
Methods to Measure MDSC Immune Suppressive Activity In Vitro and In Vivo 128
Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. 127
Myeloid-derived suppressor cells generated in vitro 127
In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancer. 126
La risposta immunologica verso antigeni tumorali specifici 126
Extracellular ATP as a possible mediator of cell-mediated cytotoxicity. 124
Interaction of human pancreatic ductal adenocarcinoma cells with polymeric scaffolds to develop tissue-engineered cancer models. 124
Therapeutic effectiveness of recombinant cancer vaccines is associated with a prevalent T-cell receptor alpha usage by melanoma-specific CD8+ T lymphocytes. 123
Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes. 123
Totale 17.032
Salva come PNG Salva come JPEG
Categoria #
all - tutte 99.624
article - articoli 89.181
book - libri 0
conference - conferenze 1.906
curatela - curatele 0
other - altro 1.575
patent - brevetti 1.847
selected - selezionate 0
volume - volumi 5.115
Totale 199.248
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021327 0 0 0 0 0 0 0 0 0 37 203 87
2021/20221.735 106 442 31 52 74 47 70 111 115 89 151 447
2022/20232.728 257 262 303 445 230 632 42 154 294 14 57 38
2023/20241.516 63 98 101 192 209 236 66 140 16 87 239 69
2024/20254.793 275 271 146 710 273 163 330 306 828 281 354 856
2025/202611.761 995 635 782 1.783 2.807 870 1.470 682 1.065 672 0 0
Totale 30.522